![The ALS Association, Huntington's Disease Society of America, and Teva Pharmaceuticals Launch Teva CNS Target Identification Challenge | The ALS Association The ALS Association, Huntington's Disease Society of America, and Teva Pharmaceuticals Launch Teva CNS Target Identification Challenge | The ALS Association](https://www.als.org/sites/default/files/styles/hero_image/public/blog_files/press-release-image-cropped1.jpg?h=1602cc36&itok=fiN1NDbD)
The ALS Association, Huntington's Disease Society of America, and Teva Pharmaceuticals Launch Teva CNS Target Identification Challenge | The ALS Association
![Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire](https://mms.businesswire.com/media/20210831005934/en/902034/23/MedinCell_LOGO.jpg)
Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire
![Teva Pharmaceutical CEO Shlomo Yanai delivers a press conference in Cologne, Germany, 18 March 2010. German generics producer Ratiopharm is sold to world's leading generic producer Teva Pharmaceutical at 3.625 billion euro. Teva Pharmaceutical CEO Shlomo Yanai delivers a press conference in Cologne, Germany, 18 March 2010. German generics producer Ratiopharm is sold to world's leading generic producer Teva Pharmaceutical at 3.625 billion euro.](https://c8.alamy.com/comp/D56P1T/teva-pharmaceutical-ceo-shlomo-yanai-delivers-a-press-conference-in-D56P1T.jpg)
Teva Pharmaceutical CEO Shlomo Yanai delivers a press conference in Cologne, Germany, 18 March 2010. German generics producer Ratiopharm is sold to world's leading generic producer Teva Pharmaceutical at 3.625 billion euro.
![Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes | Business Wire Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes | Business Wire](https://mms.businesswire.com/media/20211027005515/en/739014/22/teva_RGB_JPEG.jpg)
Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes | Business Wire
![Teva Pharmaceuticals Launches Generic EpiPen for Children in US | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Av 5779 – August 21, 2019 | JewishPress.com Teva Pharmaceuticals Launches Generic EpiPen for Children in US | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Av 5779 – August 21, 2019 | JewishPress.com](https://www.jewishpress.com/wp-content/uploads/TEVA-Pharmaceutical-Industries-headquarters-outside-Jerusalem.jpg)
Teva Pharmaceuticals Launches Generic EpiPen for Children in US | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Av 5779 – August 21, 2019 | JewishPress.com
![Teva Pharmaceutical Industries Limited 2022 Q1 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha Teva Pharmaceutical Industries Limited 2022 Q1 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha](https://static1.seekingalpha.com/uploads/sa_presentations/456/82456/slides/2.jpg?0)
Teva Pharmaceutical Industries Limited 2022 Q1 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
![Teva Pharmaceuticals on Twitter: "CEO Kåre Schultz and members of Teva's leadership team shared #quarterlyresults and updates during today's Q3 2021 #earnings webcast. Access a replay here:https://t.co/wDrj765YCy Forward-looking statements are subject to Teva Pharmaceuticals on Twitter: "CEO Kåre Schultz and members of Teva's leadership team shared #quarterlyresults and updates during today's Q3 2021 #earnings webcast. Access a replay here:https://t.co/wDrj765YCy Forward-looking statements are subject to](https://pbs.twimg.com/media/FCuXMz3X0AU81CB.jpg:large)
Teva Pharmaceuticals on Twitter: "CEO Kåre Schultz and members of Teva's leadership team shared #quarterlyresults and updates during today's Q3 2021 #earnings webcast. Access a replay here:https://t.co/wDrj765YCy Forward-looking statements are subject to
![AlivaMab Discovery Services Announces Multi-Target Agreement with Teva Pharmaceuticals | Business Wire AlivaMab Discovery Services Announces Multi-Target Agreement with Teva Pharmaceuticals | Business Wire](https://mms.businesswire.com/media/20210914005047/en/905122/23/AlivaMab-DS-logo.jpg)
AlivaMab Discovery Services Announces Multi-Target Agreement with Teva Pharmaceuticals | Business Wire
![Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes | Business Wire Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes | Business Wire](https://mms.businesswire.com/media/20211027005515/en/739014/23/teva_RGB_JPEG.jpg)